Novo Nordisk A/S

Novo Terapeutisk Laboratorium A/S
Novo Alle 1
2880, Bagsværd , Hovedstaden Denmark
+45-44448888
Company Type: Limited Liability Company Subsidiary

Novo Nordisk is one of the world's leading producers of diabetes therapies including human insulin, insulin analogues, and injection devices. It makes modern insulin analogues Levemir and NovoLog (which mimic natural insulin regulation more closely than human insulin), Victoza for type 2 diabetes, and Saxenda, which treats obesity. The firm also has products in the areas of hemostasis management (blood clotting), human growth hormone, and estrogen replacement therapy. The company has affiliates in some 80 countries and markets products in about 170 countries. The not-for-profit Novo Nordisk Foundation, through its Novo A/S subsidiary, controls the voting power in Novo Nordisk.

Try D&B Hoovers Free

Financial Statements

Financial data as of December 31, 2019 (12 month period) in USD

Annual Revenue 2019
$18.06 billionUSD
1 USD = 6.7549 DKK

Dun & Bradstreet collects private company financials for more than 23 million companies in over 200 countries. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (This Site) 1,000
  • ASSETS (MIL USD) 18,596
  •  SALES (MIL USD) 18,063.99
  • TICKER SYMBOL NOVO B
  • FISCAL YEAR END DEC
  • SALES GROWTH % 9.11%
  • NET INCOME GROWTH 0.84%

Get in Touch with 2 Contacts

A D&B Hoovers Subscription is your foot in the door to Novo Nordisk A/S contact information.
  • Lars Fruergaard Jørgensen
    Managing Director
  • Stig Strøbæk
    Staff representative on the board
  • Andreas Helmut Fibig
    Board Member
  • Martin William Mackay
    Board Member
See full contact details
Start Your Free Trial

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Novo Nordisk A/S

Novo Nordisk A/S

2
Contacts
Reach the right people with access to detailed contact information.
355
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.